BioNTech SE American Depositary Share

BNTX XNAS

Market Cap

23B

Short interest (May 15)

1.0%

Net Short (Jun 03 ): 0.0%

Borrow Fee

0.59%

↑ 100.2%

Available Shares

900K

↓ 24.4%

Price Chart

Company Overview

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.

Company Info

Exchange: NASDAQ
CIK: 0001776985
Asset Type: ADRC

Market Data

Market Cap: $22,542,103,025
Employees: 7,807
Status: Active

Short Interest

Current Borrow Fee 0.59%
Range: 0.56% - 0.61%
Available Shares 900K
Range: 800K - 900K

Recent Changes

Fee Change: ↓ 16.2%
Available Change: ↓ 0.0%

Quick Actions

View Dilution Chart
Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam Unsubscribe anytime